2020

1. Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial

   The Lancet Neurology, Vol. 19, Núm. 3, pp. 226-233